Relationship between viral load and symptoms in children infected with SARS-CoV-2.


Journal

Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714

Informations de publication

Date de publication:
03 2023
Historique:
received: 19 03 2022
accepted: 22 08 2022
revised: 15 08 2022
pubmed: 8 9 2022
medline: 25 3 2023
entrez: 7 9 2022
Statut: ppublish

Résumé

The purpose of this study is to evaluate the association between SARS-CoV-2 viral load in respiratory secretions of infected children and signs/symptoms of COVID-19. We reported the clinical characteristics of SARS-CoV-2-infected children during the study period. We compared viral load for several clinical variables, performed a predictive linear regression analysis to identify signs and symptoms significantly associated with viral load, and searched for discriminant viral load thresholds for symptomatic versus asymptomatic infections based on receiver-operating characteristics. A total of 570 patients were included. The median age was 4.75 years. Comparison of CT values by dichotomous variable showed higher viral loads in children with fever, respiratory symptoms, and previous exposure to SARS-CoV-2. The linear regression analysis confirmed a significant relationship between the CT value with these variables and with age, other symptoms, and asymptomaticity. In particular, infants with fever and SARS-CoV-2 exposure had higher viral loads. No viral load cut-offs were found to distinguish symptomatic from asymptomatic patients. Our study shows that fever, SARS-CoV-2 exposure, and respiratory symptoms are associated with higher viral load in children, especially infants, while age, presence of nonrespiratory symptoms, or absence of any symptoms are associated with lower viral load. Key message: the clinical variables that best predict viral load in infected children are history of previous exposure to a SARS-CoV-2-infected person and presence of fever and respiratory symptoms (higher viral load). Added value to the current literature: this is the first article to prove this point. SARS-CoV-2 viral load should not be used as a measure of clinical severity of COVID-19 in the pediatric population; however, lower viral load appears to be associated with asymptomatic COVID-19 in older children.

Sections du résumé

BACKGROUND
The purpose of this study is to evaluate the association between SARS-CoV-2 viral load in respiratory secretions of infected children and signs/symptoms of COVID-19.
METHODS
We reported the clinical characteristics of SARS-CoV-2-infected children during the study period. We compared viral load for several clinical variables, performed a predictive linear regression analysis to identify signs and symptoms significantly associated with viral load, and searched for discriminant viral load thresholds for symptomatic versus asymptomatic infections based on receiver-operating characteristics.
RESULTS
A total of 570 patients were included. The median age was 4.75 years. Comparison of CT values by dichotomous variable showed higher viral loads in children with fever, respiratory symptoms, and previous exposure to SARS-CoV-2. The linear regression analysis confirmed a significant relationship between the CT value with these variables and with age, other symptoms, and asymptomaticity. In particular, infants with fever and SARS-CoV-2 exposure had higher viral loads. No viral load cut-offs were found to distinguish symptomatic from asymptomatic patients.
CONCLUSION
Our study shows that fever, SARS-CoV-2 exposure, and respiratory symptoms are associated with higher viral load in children, especially infants, while age, presence of nonrespiratory symptoms, or absence of any symptoms are associated with lower viral load.
IMPACT
Key message: the clinical variables that best predict viral load in infected children are history of previous exposure to a SARS-CoV-2-infected person and presence of fever and respiratory symptoms (higher viral load). Added value to the current literature: this is the first article to prove this point.
IMPACT
SARS-CoV-2 viral load should not be used as a measure of clinical severity of COVID-19 in the pediatric population; however, lower viral load appears to be associated with asymptomatic COVID-19 in older children.

Identifiants

pubmed: 36071238
doi: 10.1038/s41390-022-02293-4
pii: 10.1038/s41390-022-02293-4
pmc: PMC9451120
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

897-904

Informations de copyright

© 2022. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Références

Italian National Health Institute (Istituto Superiore di Sanità). Coronavirus epidemic: situation report. https://www.epicentro.iss.it/coronavirus/bollettino/Bolletino-sorveglianza-integrata-COVID-19_3-agosto-2022.pdf .
Qi, K. et al. Clinical, laboratory, and imaging features of pediatric COVID-19: a systematic review and meta-analysis. Medicine (Baltimore) 100, e25230 (2021).
Roversi, M. et al. Diagnosis of COVID-19 in children guided by lack of fever and exposure to SARS-CoV-2. Pediatr. Res. 11, 1–7 (2021).
Yu, F. et al. Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients. Clin. Infect. Dis. 71, 793–798 (2020).
doi: 10.1093/cid/ciaa345 pubmed: 32221523
Baggio, S. et al. Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) viral load in the upper respiratory tract of children and adults with early acute coronavirus disease 2019 (COVID-19). Clin. Infect. Dis. 73, 148–150 (2021).
doi: 10.1093/cid/ciaa1157 pubmed: 32761228
Amy, E. et al. SARS-CoV-2 viral load peaks prior to symptom onset: a systematic review and individual-pooled analysis of coronavirus viral load from 66 studies. Preprint at https://www.medrxiv.org/content/10.1101/2020.09.28.20202028v1 (2020).
Néant, N. et al. Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort. Proc. Natl Acad. Sci. USA. 118, e2017962118 (2021).
doi: 10.1073/pnas.2017962118 pubmed: 33536313 pmcid: 7929555
Yonker, L. M. et al. Virologic features of severe acute respiratory syndrome coronavirus 2 infection in children. J. Infect. Dis. 224, 1821–1829 (2021).
doi: 10.1093/infdis/jiab509 pubmed: 34647601 pmcid: 8643403
Madera, S. et al. Nasopharyngeal SARS-CoV-2 viral loads in young children do not differ significantly from those in older children and adults. Sci. Rep. 11, 3044 (2021).
doi: 10.1038/s41598-021-81934-w pubmed: 33542262 pmcid: 7862672
Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities. Interim guidance. WHO. 25 June 2021. https://apps.who.int/iris/bitstream/handle/10665/342002/WHO-2019-nCoV-lab-testing-2021.1-eng.pdf?sequence=1&isAllowed=y .
Tom, M. R. & Mina, M. J. To interpret the SARS-CoV-2 test, consider the cycle threshold value. Clin. Infect. Dis. 71, 2252–2254 (2020).
doi: 10.1093/cid/ciaa619 pubmed: 32435816
Bullard, J. et al. Infectivity of severe acute respiratory syndrome coronavirus 2 in children compared with adults. CMAJ 193, E601–E606 (2021).
doi: 10.1503/cmaj.210263 pubmed: 33837039 pmcid: 8101972
Piralla, A. et al. Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: is prolonged quarantine always justified? Int. J. Infect. Dis. 102, 299–302 (2021).
doi: 10.1016/j.ijid.2020.10.072 pubmed: 33130202
Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eur. Surveill. 25, 2000045 (2020).
doi: 10.2807/1560-7917.ES.2020.25.3.2000045
Sung, H. et al. Nationwide external quality assessment of SARS-CoV-2 molecular testing, South Korea. Emerg. Infect. Dis. 26, 2353–2360 (2020).
doi: 10.3201/eid2610.202551 pubmed: 32723432 pmcid: 7510727
Dahdouh, E., Lázaro-Perona, F., Romero-Gómez, M. P., Mingorance, J. & García-Rodriguez, J. Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load. J. Infect. 82, 414–451 (2021).
doi: 10.1016/j.jinf.2020.10.017 pubmed: 33131699
Faíco-Filho, K. S., Passarelli, V. C. & Bellei, N. Is higher viral load in SARS-CoV-2 associated with death? Am. J. Trop. Med. Hyg. 103, 2019–2021 (2020).
doi: 10.4269/ajtmh.20-0954 pubmed: 32996443 pmcid: 7646800
Huang, J. T. et al. Chronological changes of viral shedding in adult inpatients with COVID-19 in Wuhan, China. Clin. Infect. Dis. 71, 2158–2166 (2020).
doi: 10.1093/cid/ciaa631 pubmed: 32445580
Magleby, R. et al. Impact of SARS-CoV-2 viral load on risk of intubation and mortality among hospitalized patients with coronavirus disease 2019. Clin. Infect. Dis. 73, e4197–e4205 (2020).
doi: 10.1093/cid/ciaa851 pmcid: 7337625
Rhee, C., Kanjilal, S., Baker, M. & Klompas, M. Duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity: when is it safe to discontinue isolation? Clin. Infect. Dis. 72, 1467–1474 (2021).
doi: 10.1093/cid/ciaa1249 pubmed: 33029620
Miller, E. H. et al. Pretest symptom duration and cycle threshold values for severe acute respiratory syndrome Coronavirus 2 reverse-transcription polymerase chain reaction predict coronavirus disease 2019 mortality. Open Forum Infect. Dis. 8, ofab003 (2021).
doi: 10.1093/ofid/ofab003 pubmed: 33604401 pmcid: 7798567
Silva Júnior, J. V. J. et al. End-point RT-PCR: a potential alternative for diagnosing coronavirus disease 2019 (COVID-19). J. Virol. Methods 288, 114007 (2021).
doi: 10.1016/j.jviromet.2020.114007 pubmed: 33130151
Rabaan, A. A. et al. Viral dynamics and real-time RT-PCR Ct values correlation with disease severity in COVID-19. Diagnostics (Basel) 11, 1091 (2021).
doi: 10.3390/diagnostics11061091 pubmed: 34203738
El Zein, S. et al. SARS-CoV-2 infection: initial viral load (iVL) predicts severity of illness/outcome, and declining trend of iVL in hospitalized patients corresponds with slowing of the pandemic. PLoS One 16, e0255981 (2021).
doi: 10.1371/journal.pone.0255981 pubmed: 34529675 pmcid: 8445469
Quiroga, S. A. et al. Contrasting SARS-CoV-2 RNA copies and clinical symptoms in a large cohort of Colombian patients during the first wave of the COVID-19 pandemic. Ann. Clin. Microbiol. Antimicrob. 20, 39 (2021).
doi: 10.1186/s12941-021-00445-8 pubmed: 34030702 pmcid: 8142070
Lennon, N. J. et al. LB-11. Comparison of viral loads in individuals with or without symptoms at time of COVID-19 testing among 32,480 residents and staff of nursing homes and assisted living facilities in Massachusetts. Open. Forum Infect. Dis. 7, S848–S849, https://clinicaltrialsgov/show/NCT02750826 (2020).
doi: 10.1093/ofid/ofaa515.1908 pmcid: 7777564
Borrelli, M., Corcione, A., Castellano, F., Fiori Nastro, F. & Santamaria, F. Coronavirus disease 2019 in children. Front. Pediatr. 9, 668484 (2021).
doi: 10.3389/fped.2021.668484 pubmed: 34123972 pmcid: 8193095
Christakis, D. A. Pediatrics and COVID-19. JAMA 324, 1147–1148 (2020).
doi: 10.1001/jama.2020.14297 pubmed: 32960248
Ludvigsson, J. F. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 109, 1088–1095 (2020).
doi: 10.1111/apa.15270 pubmed: 32202343 pmcid: 7228328
Raju, S. et al. Comparison of 6 SARS-CoV-2 molecular methods and correlation with the cycle threshold distribution in clinical specimens. J. Appl. Lab. Med. 6, 1452–1462 (2021).
Italian National Health Institute (Istituto Superiore di Sanità). Monitoraggio delle varianti del virus SARS-CoV-2 di interesse in sanità pubblica in Italia. https://www.epicentro.iss.it/coronavirus/pdf/sars-cov-2-monitoraggio-varianti-rapporti-periodici-25-giugno-2021.pdf .

Auteurs

Marco Roversi (M)

Residency School of Pediatrics, University of Rome Tor Vergata, Rome, Italy.

Luana Coltella (L)

Microbiology and Immunology Diagnostics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Livia Piccioni (L)

Microbiology and Immunology Diagnostics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Umberto Raucci (U)

Department of Emergency, Acceptance and General Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. umberto.raucci@opbg.net.

Antonio Torelli (A)

Residency School of Pediatrics, University of Rome Tor Vergata, Rome, Italy.

Laura Papini (L)

Department of Emergency, Acceptance and General Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Carla Olita (C)

Department of Emergency, Acceptance and General Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Antonino Reale (A)

Department of Emergency, Acceptance and General Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Carlo Federico Perno (CF)

Microbiology and Immunology Diagnostics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Alberto Villani (A)

Department of Emergency, Acceptance and General Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Systems Medicine Department, University of Rome Tor Vergata, Rome, Italy.

Cristina Russo (C)

Microbiology and Immunology Diagnostics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH